222 related articles for article (PubMed ID: 36219557)
1. Construction of an rAAV Producer Cell Line through Synthetic Biology.
Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
Lin YC; Lu M; Cai W; Hu WS
Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
[TBL] [Abstract][Full Text] [Related]
4. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
5. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
6. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
8. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
9. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
10. Development of an Inducible, Replication-Competent Assay Cell Line for Titration of Infectious Recombinant Adeno-Associated Virus Vectors.
Lee Z; Lu M; Irfanullah E; Soukup M; Schmidt D; Hu WS
Hum Gene Ther; 2023 Feb; 34(3-4):162-170. PubMed ID: 36565023
[TBL] [Abstract][Full Text] [Related]
11. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
Xiao X; Li J; Samulski RJ
J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
[TBL] [Abstract][Full Text] [Related]
12. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity.
Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS
Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988
[TBL] [Abstract][Full Text] [Related]
13. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the production of recombinant adeno-associated virus in synthetic cell lines through systematic characterization.
Lu M; Lee Z; Lin YC; Irfanullah I; Cai W; Hu WS
Biotechnol Bioeng; 2024 Jan; 121(1):341-354. PubMed ID: 37749931
[TBL] [Abstract][Full Text] [Related]
15. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes.
Qiao C; Li J; Skold A; Zhang X; Xiao X
J Virol; 2002 Feb; 76(4):1904-13. PubMed ID: 11799185
[TBL] [Abstract][Full Text] [Related]
17. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
[TBL] [Abstract][Full Text] [Related]
18. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy.
Dong B; Moore AR; Dai J; Roberts S; Chu K; Kapranov P; Moss B; Xiao W
Nucleic Acids Res; 2013 Jul; 41(13):6609-17. PubMed ID: 23677609
[TBL] [Abstract][Full Text] [Related]
19. AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.
Su W; Seymour LW; Cawood R
Sci Rep; 2023 Dec; 13(1):21670. PubMed ID: 38066084
[TBL] [Abstract][Full Text] [Related]
20. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
